Winners of the 2026 Ideas with Impact Awards Announced: Meet the donor-funded entrepreneurs driving impact through innovation
On Thursday 2nd July, the ten finalists of the 2026 Ideas with Impact Awards came together in Whitworth Hall at The University of 野狼社区 to pitch their early-stage venture plans, for the chance to win a share of 拢350,000 in prize funding.
Open to innovators across all disciplines, the awards are made possible by our generous community of donors as part of our Challenge Accepted campaign. The final total raised for 2026 reached 拢350,000, including a new gift from CMSPI, to establish The CMSPI Future Technologies Prize.
Ideas with Impact provides winners with funding, expert mentoring and access to a network of founders and innovators, giving them the support and connections needed to turn promising ideas into impactful ventures. The awards are open to University staff, students, and recent alumni, and aim to support entrepreneurs with innovative solutions to the world鈥檚 most pressing issues.
This year鈥檚 finalists 鈥 whittled down from over 170 applications 鈥 drew from a range of disciplines, from operating electrical power systems and zero-carbon fusion energy generation, to blood cancer treatment and countering antimicrobial resistance.
We are delighted to introduce this year鈥檚 winners and their ventures 鈥
拢100,000&苍产蝉辫;鈥&苍产蝉辫;厂飞颈蹿迟颁补蝉&苍产蝉辫;顿颈补驳苍辞蝉迟颈肠蝉
We have developed simple, fast diagnostic tests that use CRISPR programmable nuclease technology to identify infections caused by a wide range of infectious agents, especially bacteria. Our approach can be easily adapted to detect different diseases, making it highly flexible. CRISPR diagnostic tests are accurate, affordable, and rapid. These tests will help doctors diagnose infections and make informed treatment decisions within hours of assessing a patient, rather than after waiting several days for results. By speeding up diagnosis and improving precision, our technology has the potential to improve patient outcomes, reduce healthcare burden and limit the unnecessary use of antibiotics.
拢75,000 鈥 Monoblast Therapeutics
We are developing a first-in-class targeted therapy for Chronic Myelomonocytic Leukaemia (CMML), a rare blood cancer with no effective treatments and a median survival of 18鈥24 months. Our approach uses novel compounds conjugated to CCL2, a protein selectively taken up by disease-causing cells in CMML. Recent findings show that our third-generation CCL2-STING conjugates trigger rapid cell death in CMML monocytes, offering potential for superior efficacy and safety margin. Targeting a ~$1Bn market with broader immuno-oncology potential, we aim to seek partnerships with pharmaceutical companies to advance these therapies with the aim of providing transformational therapy to CMML patients.
拢75,000 鈥 Fibrametric (The CMSPI Future Technologies Prize)
Every time we wash and wear our clothes, microscopic fibres are released into the environment carrying harmful chemicals including heavy metals and persistent pollutants, yet there is no standard way to monitor fibre release. We are developing an automated microfibre testing platform for textile laboratories that combines advanced imaging with repeatable analysis to accurately measure and understand fibre release. Designed to integrate directly into existing textile testing workflows, this system enables manufacturers, researchers and regulators to generate comparable evidence, support emerging standards and accelerate the development of lower-polluting textile products.
拢50,000 鈥 Grid Stability
Grid Stability Monitor (GSM) is an Artificial Intelligence (AI)-powered solution that supports stable and secure operation of electrical power systems. As renewable generation and low-carbon technologies continue to grow to achieve decarbonisation targets, existing assessment tools struggle to evaluate network stability risks quickly enough across the huge number of possible operating conditions/contingencies. GSM enables rapid stability assessment and better understanding of potential hidden underlying risks, supporting economical, on-demand procurement of stability services where and when needed. This unlocks effective use of low carbon technologies, thereby overcoming a substantial barrier to decarbonising our energy use, while keeping the lights on.
拢50,000&苍产蝉辫;鈥&苍产蝉辫;搁补诲颈辞痴颈蝉颈辞苍
Commercial drones increasingly exploit 4G/5G networks for long-range operations, exposing a critical security gap that traditional countermeasures miss. Our technology overcomes this challenge, leveraging advanced radio sensing with AI to passively analyse cellular network signalling鈥攚ithout touching user data. This allows us to instantly identify, and track network-connected drones disguised as regular mobile users for illegal activities. The system enables rapid global deployment to monitor any 4G/5G network, delivering robust, proactive protection against next-generation aerial threats to secure critical infrastructure and airspace.
These successful ventures will join a community of former winners, who have used their funding to deliver real-world impact. Alexander Stokes was one of last year鈥檚 winners as part of the team 鈥 a University of 野狼社区 spinout working to improve the accuracy of diagnoses for heart attacks and cardiovascular disease. Imprinted Diagnostics is now raising seed funding to support its next stage of growth and impact.
It was the starting fuel we needed to grow the company to what we are today, a core team of 5 and a wider network of 30+ partners all working together to deliver one common goal of a portable blood test for heart attacks.
Another previous winner, Kay Marshall of MollaPharm, gave an update at this year鈥檚 awards. Working towards treating endometriosis through next-generation therapeutic conditions, Marshall praised the nature of the prize, 鈥淭he no strings approach adopted by Ideas with Impact has enabled our speedy progression, where red tape frequently slows things down - this has allowed us to push our invention forward faster so we can reach the women with endometriosis sooner rather than later.鈥
Our Vice President for Civic Engagement and Innovation, Professor John Holden said, 鈥淎cross our University community, talented people are developing bold ideas with the potential to improve lives, create opportunities and tackle some of society鈥檚 biggest challenges. Thanks to the generosity of our donors, we鈥檙e able to help turn that potential into reality through Ideas with Impact, supporting innovators at a crucial stage of their journey and helping ensure great ideas can deliver meaningful impact across 野狼社区 and beyond.鈥
The judging panel said, 鈥淭he finalists this year exemplify the bold thinking, creativity and determination needed to tackle some of the most pressing challenges facing society today. As a judging panel, we were inspired not only by the calibre of ideas, but by the passion, commitment and entrepreneurial spirit of the people behind them. Ideas with Impact is about creating the conditions for innovators to transform promising ideas into ventures that deliver real-world change. We look forward to seeing how this year鈥檚 winners build on their success and create lasting impact in the years ahead.鈥
- Professor Aline Miller 鈥 Associate Vice President (Enterprise) at The University of 野狼社区
- Dr Ewelina Rozycka-Burn 鈥 Head of Commercial Development at The University of 野狼社区 Innovation Factory
- Professor Lee Pugalis 鈥 Interim Director, The Masood Entrepreneurship Centre
- Professor Sarah Underwood 鈥 Head of the Strategy, Enterprise & Sustainability Department and University Academic Lead for Commercialisation at 野狼社区 Metropolitan University
Learn more about philanthropic support
Innovation is at the heart of the University鈥檚 Challenge Accepted campaign, fuelling our ambition to become Europe鈥檚 most inclusive and impactful innovation network, and helping deliver progress that changes lives.
Are you interested in supporting brilliant future founders and ensuring entrepreneurship for all? We鈥檇 love to explore opportunities with you.
Contact Olympia Kennard to begin a conversation: Olympia.Kennard@manchester.ac.uk.